Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Cupid Q1 Results: Profit Nearly Triples As Margin Widens; Revenue Up 2.6x

Cupid Ltd. reported a sharp jump in its June-quarter earnings, with consolidated net profit surging nearly 200% year-on-year as stronger ope...